Post-effective amendment to a registration statement that is not immediately effective upon filing

EQUITY (Detail Textuals 1)

v3.20.1
EQUITY (Detail Textuals 1) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 25, 2019
Nov. 30, 2019
Nov. 30, 2018
Aug. 31, 2019
Aug. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation   $ 13,000   $ 52,000 $ 56,835
Remains unamortized stock base expenses   $ 82,833      
Number of shares granted during period   0   184,000 50,000
Number of units sold 1,300,813        
Value for issuance of common shares     $ 170,774 $ 8,376,379 $ 1,386,613
Exercise price of warrants $ 6.4575        
Derivative liability       $ 29,501  
Number of warrant to purchase common stock 1        
Common stock, par value (in dollars per share) $ 0.001 $ 0.001   $ 0.001 $ 0.001
Warrant intrinsic value   $ 0     $ 585,691
Over-allotment option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Exercise price of warrants $ 6.765        
Number of warrant to purchase common stock 104,065        
Percentage of underwriting discounts and commissions 8.00%        
Offering price, per unit $ 6.15        
Stock purchase agreement | Series A or Series B Common Stock Purchase Warrant | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Exercise price of warrants       14.00  
Stock purchase agreement | Series A or Series B Common Stock Purchase Warrant | Minimum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Exercise price of warrants       $ 8.00  
Director          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of restricted shares award issued       65,000  
NEOMED          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of units sold       72,660  
Number of shares issued during period       61,297  
Value for issuance of common shares       $ 539,417  
Shares issued for settlement of accrued liability       11,363  
Value for shares issued for settlement of accrued liability       $ 100,000  
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation   155,019      
Remains unamortized stock base expenses   $ 482,847      
Number of shares granted during period   234,000      
Intrinsic value   $ 81,312      
Value of the remaining life of the options   9 years 6 months 10 days